Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors
Journal of Child and Adolescent Psychopharmacology · 01.05.2022 · 32 (4) · 233-241
DOI: 10.1089/cap.2021.0137 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, erschienen am 01.05.2022. Verfasst von Emily Simonoff und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child & Adolescent Psychiatry and Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Citalopram. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child & Adolescent Psychiatry and Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
- Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience and Maudsley Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom.
- Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.
- Department of Pediatrics, University of Toronto, Toronto, Canada.
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
- Autism and Obsessive Compulsive Spectrum Program, Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, New York, USA.
ORCID-Profile: Oliver Pearson
Förderung
- NIMH NIH HHS
Zitieren
APA
Simonoff, E., Mowlem, F., Pearson, O., Anagnostou, E., Donnelly, C., Hollander, E., King, B. H., McCracken, J. T., Scahill, L., Sikich, L., & Pickles, A. (2022). Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology, 32(4), 233-241. https://doi.org/10.1089/cap.2021.0137
Vancouver
Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, et al. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 2022;32(4):233-241. doi:10.1089/cap.2021.0137
BibTeX
@article{Simonoff2022,
author = {Simonoff, Emily and Mowlem, Florence and Pearson, Oliver and Anagnostou, Evdokia and Donnelly, Craig and Hollander, Eric and King, Bryan H and McCracken, James T and Scahill, Lawrence and Sikich, Linmarie and Pickles, Andrew},
title = {Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2022},
volume = {32},
number = {4},
pages = {233--241},
doi = {10.1089/cap.2021.0137}
}
EUVIMED